ADVERTISEMENT

Clinical Summary

Non-small cell lung cancer: survival after liquid biopsy-guided therapy

Miriam Davis, PhD   |   24 November 2022

Takeaway

  • The use of circulating tumour DNA (ctDNA)-guided therapy (also known as liquid biopsy-guided therapy) improves the survival of patients with NSCLC, according to a large international cohort with long follow-up.

Why this matters

  • Sequencing of ctDNA is a new method that uses plasma instead of tissue specimens to find targetable mutations in...

          

Topic Challenges

left
right